These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. Brunner J; Sitzmann FC Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438 [TBL] [Abstract][Full Text] [Related]
5. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [TBL] [Abstract][Full Text] [Related]
6. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Kamphuis S; Hrafnkelsdóttir K; Klein MR; de Jager W; Haverkamp MH; van Bilsen JH; Albani S; Kuis W; Wauben MH; Prakken BJ Arthritis Res Ther; 2006; 8(6):R178. PubMed ID: 17129378 [TBL] [Abstract][Full Text] [Related]
7. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Brunner JK; Sitzmann FC Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999 [TBL] [Abstract][Full Text] [Related]
8. High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy. Mor-Vaknin N; Rivas M; Legendre M; Mohan S; Yuanfan Y; Mau T; Johnson A; Huang B; Zhao L; Kimura Y; Spalding SJ; Morris PW; Gottlieb BS; Onel K; Olson JC; Edelheit BS; Shishov M; Jung LK; Cassidy EA; Prahalad S; Passo MH; Beukelman T; Mehta J; Giannini EH; Adams BS; Lovell DJ; Markovitz DM Arthritis Rheumatol; 2018 Apr; 70(4):594-605. PubMed ID: 29287303 [TBL] [Abstract][Full Text] [Related]
9. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and Gastrointestinal Symptoms in Colombian Children with Juvenile Idiopathic Arthritis. Gonzalez T; Malagon C; Guarnizo P; Mosquera AC; Chila-Moreno L; Romero-Sanchez C Curr Rheumatol Rev; 2018; 14(2):163-171. PubMed ID: 29308742 [TBL] [Abstract][Full Text] [Related]
13. Anti-α-1,4-D-polygalacturonic acid antibodies as a new biomarker for juvenile idiopathic arthritis. Huang J; Wu Z; Quan W; Ye X; Dai X; Luo J; Han X; Li X; Zheng W Clin Rheumatol; 2024 Sep; 43(9):2919-2926. PubMed ID: 38997543 [TBL] [Abstract][Full Text] [Related]
14. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. Zlacka D; Vavrincova P; Hien Nguyen TT; Hromadnikova I J Autoimmun; 2006 Sep; 27(2):81-8. PubMed ID: 16934956 [TBL] [Abstract][Full Text] [Related]
15. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Lange L; Thiele GM; McCracken C; Wang G; Ponder LA; Angeles-Han ST; Rouster-Stevens KA; Hersh AO; Vogler LB; Bohnsack JF; Abramowicz S; Mikuls TR; Prahalad S Pediatr Rheumatol Online J; 2016 Feb; 14(1):8. PubMed ID: 26861944 [TBL] [Abstract][Full Text] [Related]
16. Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis. Bloom BJ; Toyoda M; Petrosian A; Jordan S Rheumatol Int; 2007 May; 27(7):655-60. PubMed ID: 17165085 [TBL] [Abstract][Full Text] [Related]
17. Radiobinding assay for detecting autoantibodies to single epitopes. Lampasona V; Belloni C; Piquer S; Bonicchio S; Furlan R; Bonifacio E J Immunol Methods; 2008 Jul; 336(2):127-34. PubMed ID: 18501377 [TBL] [Abstract][Full Text] [Related]
18. Prior to extension, Transcriptomes of fibroblast-like Synoviocytes from extended and Polyarticular juvenile idiopathic arthritis are indistinguishable. Brescia AC; Simonds MM; McCahan SM; Sullivan KE; Rose CD Pediatr Rheumatol Online J; 2018 Jan; 16(1):3. PubMed ID: 29310668 [TBL] [Abstract][Full Text] [Related]
19. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866 [TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of the N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease. Di Pisa M; Buccato P; Sabatino G; Real Fernández F; Berti B; Cocola F; Papini AM; Rovero P J Pept Sci; 2014 Sep; 20(9):689-95. PubMed ID: 24831711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]